Last reviewed · How we verify
Evaluation of Almotriptan and Topiramate in the Detoxification and Treatment of Subjects With Medication Overuse Headache
The purpose of this study is to assess the benefits of almotriptan used as a transitional therapy and topiramate in subjects with medication overuse headaches (MOH.
Details
| Lead sponsor | The New England Center for Headache, P.C. |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 60 |
| Start date | 2007-01 |
| Completion | 2007-02 |
Conditions
- Analgesic Rebound Headache
Interventions
- Almotriptan
- Topiramate
Primary outcomes
- Primary measure for the detoxification period
- Number of days with mild or no pain in the first two weeks of treatment
- Primary for the prevention of relapse
- Pain free days through day ninety
Countries
United States